Compound ID | 1053
Class: Aminoglycoside
Spectrum of activity: | Gram-negative |
Details of activity: | Glucosyltransferase inhibitor |
Institute where first reported: | The UpJohn Company |
Year first mentioned: | 1976 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
Reason Dropped: | "lack of clinical promise" |
Chemical structure(s): | |
Canonical SMILES: | C([C@@H]1[C@H]([C@@H]([C@H](C(N1)O)O)O)O)O |
Isomeric SMILES: | C([C@@H]1[C@H]([C@@H]([C@H](C(N1)O)O)O)O)O |
InChI: | InChI=1S/C6H13NO5/c8-1-2-3(9)4(10)5(11)6(12)7-2/h2-12H,1H2/t2-,3-,4+,5-,6?/m1/s1 |
InChI Key: | BGMYHTUCJVZIRP-GASJEMHNSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/65242 |
External links: | |
Guide to Pharmacology: | nojirimycin |
Citation: | https://www.ncbi.nlm.nih.gov/pubmed/994321 |